StemCells Aktie
WKN DE: A1JCUD / ISIN: US85857R2040
|
02.11.2023 22:15:11
|
Stem, Inc. Q3 Loss increases, misses estimates
(RTTNews) - Stem, Inc. (STEM) revealed Loss for its third quarter that increased from last year and beat the Street estimates.
The company's bottom line came in at -$77.1 million, or -$0.49 per share. This compares with -$34.3 million, or -$0.22 per share, in last year's third quarter.
Analysts on average had expected the company to earn -$0.18 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 34.4% to $133.7 million from $99.5 million last year.
Stem, Inc. earnings at a glance (GAAP) :
-Earnings (Q3): -$77.1 Mln. vs. -$34.3 Mln. last year. -EPS (Q3): -$0.49 vs. -$0.22 last year. -Analyst Estimate: -$0.18 -Revenue (Q3): $133.7 Mln vs. $99.5 Mln last year.
-Guidance: Full year revenue guidance: $513mln - $613mln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu StemCells Inc.mehr Nachrichten
| Keine Nachrichten verfügbar. |